The Roles of MiRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Mar 18

PMID 32178454

Citations 52

Authors

Andrei Buruiana

Stefan Ioan Florian

Alexandru Ioan Florian

Teodora-Larisa Timis

Carmen Mihaela Mihu

Maria Miclaus

Sergiu Osan

Iona Hrapsa

Radu Constantin Cataniciu

Marius Farcas

Sergiu Susman

Affiliations

Soon will be listed here.

Abstract

Glioblastoma (GBM) consists of a heterogeneous collection of competing cellular clones which communicate with each other and with the tumor microenvironment (TME). MicroRNAs (miRNAs) present various exchange mechanisms: free miRNA, extracellular vesicles (EVs), or gap junctions (GJs). GBM cells transfer miR-4519 and miR-5096 to astrocytes through GJs. Oligodendrocytes located in the invasion front present high levels of miR-219-5p, miR-219-2-3p, and miR-338-3p, all related to their differentiation. There is a reciprocal exchange between GBM cells and endothelial cells (ECs) as miR-5096 promotes angiogenesis after being transferred into ECs, whereas miR-145-5p acts as a tumor suppressor. In glioma stem cells (GSCs), miR-1587 and miR-3620-5p increase the proliferation and miR-1587 inhibits the hormone receptor co-repressor-1 () after EVs transfers. GBM-derived EVs carry miR-21 and miR-451 that are up-taken by microglia and monocytes/macrophages, promoting their proliferation. Macrophages release EVs enriched in miR-21 that are transferred to glioma cells. This bidirectional miR-21 exchange increases STAT3 activity in GBM cells and macrophages, promoting invasion, proliferation, angiogenesis, and resistance to treatment. miR-1238 is upregulated in resistant GBM clones and their EVs, conferring resistance to adjacent cells via the CAV1/EGFR signaling pathway. Decrypting these mechanisms could lead to a better patient stratification and the development of novel target therapies.

Citing Articles

Tight junction proteins in glial tumors development and progression.

Moskal J, Michalak S Front Cell Neurosci. 2025; 19:1541885.

PMID: 39963115 PMC: 11830821. DOI: 10.3389/fncel.2025.1541885.

MicroRNA-219 in the central nervous system: a potential theranostic approach.

Shamaeizadeh N, Mirian M Res Pharm Sci. 2025; 19(6):634-655.

PMID: 39911893 PMC: 11792714. DOI: 10.4103/RPS.RPS_163_23.

Unveiling cell-type-specific microRNA networks through alternative polyadenylation in glioblastoma.

Cihan M, Schmauck G, Sprang M, Andrade-Navarro M BMC Biol. 2025; 23(1):15.

PMID: 39838429 PMC: 11752630. DOI: 10.1186/s12915-024-02104-8.

Agathisflavone Inhibits Viability and Modulates the Expression of miR-125b, miR-155, IL-6, and Arginase in Glioblastoma Cells and Microglia/Macrophage Activation.

da Silva K, Lima I, Dos Santos C, Nonaka C, Souza B, David J Molecules. 2025; 30(1.

PMID: 39795214 PMC: 11721753. DOI: 10.3390/molecules30010158.

Impact of dcEF on microRNA profiles in glioblastoma and exosomes using a novel microfluidic bioreactor.

Tsai H, Shen A Biomicrofluidics. 2025; 18(6):064106.

PMID: 39742343 PMC: 11686958. DOI: 10.1063/5.0228901.

References

Qian M, Wang S, Guo X, Wang J, Zhang Z, Qiu W . Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways. Oncogene. 2019; 39(2):428-442. DOI: 10.1038/s41388-019-0996-y. View

Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z . Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019; 26(1):78. PMC: 6800990. DOI: 10.1186/s12929-019-0568-z. View

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

Zhao X, He X, Han X, Yu Y, Ye F, Chen Y . MicroRNA-mediated control of oligodendrocyte differentiation. Neuron. 2010; 65(5):612-26. PMC: 2855245. DOI: 10.1016/j.neuron.2010.02.018. View

Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F . Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer. 2012; 132(1):116-27. DOI: 10.1002/ijc.27657. View

Kim C, Nakamura M, Hsieh C . Brain trauma elicits non-canonical macrophage activation states. J Neuroinflammation. 2016; 13(1):117. PMC: 4879757. DOI: 10.1186/s12974-016-0581-z. View

DUrso P, DUrso O, Damiano Gianfreda C, Mezzolla V, Storelli C, Marsigliante S . miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma. Curr Genomics. 2016; 16(5):304-11. PMC: 4763968. DOI: 10.2174/1389202916666150707155610. View

Pu P, Xia Z, Yu S, Huang Q . Altered expression of Cx43 in astrocytic tumors. Clin Neurol Neurosurg. 2004; 107(1):49-54. DOI: 10.1016/j.clineuro.2004.03.006. View

Chen L, Zhang J, Han L, Zhang A, Zhang C, Zheng Y . Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status. Oncol Rep. 2011; 27(3):854-60. DOI: 10.3892/or.2011.1535. View

10.

Cai H, Liu X, Zheng J, Xue Y, Ma J, Xi Z . Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma. Oncogene. 2016; 36(3):318-331. DOI: 10.1038/onc.2016.212. View

11.

Thuringer D, Chanteloup G, Boucher J, Pernet N, Boudesco C, Jego G . Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cells. Oncotarget. 2017; 8(23):37681-37693. PMC: 5514940. DOI: 10.18632/oncotarget.16949. View

12.

Wang P, Zou F, Zhang X, Li H, Dulak A, Tomko Jr R . microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 2009; 69(20):8157-65. PMC: 2763324. DOI: 10.1158/0008-5472.CAN-09-1996. View

13.

Zhang S, Han L, Wei J, Shi Z, Pu P, Zhang J . Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes. Int J Oncol. 2015; 46(4):1589-600. DOI: 10.3892/ijo.2015.2841. View

14.

Kleihues P, Ohgaki H . Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol. 2001; 1(1):44-51. PMC: 1919466. DOI: 10.1093/neuonc/1.1.44. View

15.

Munoz J, Rodriguez-Cruz V, Greco S, Ramkissoon S, Ligon K, Rameshwar P . Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43. Cell Death Dis. 2014; 5:e1145. PMC: 3973225. DOI: 10.1038/cddis.2014.111. View

16.

Smits M, Wurdinger T, van Het Hof B, Drexhage J, Geerts D, Wesseling P . Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB J. 2012; 26(6):2639-47. DOI: 10.1096/fj.11-202820. View

17.

Lou W, Zhang X, Hu X, Hu A . MicroRNA-219-5p Inhibits Morphine-Induced Apoptosis by Targeting Key Cell Cycle Regulator WEE1. Med Sci Monit. 2016; 22:1872-9. PMC: 4913725. DOI: 10.12659/msm.895439. View

18.

Roth P, Wischhusen J, Happold C, Chandran P, Hofer S, Eisele G . A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem. 2011; 118(3):449-57. DOI: 10.1111/j.1471-4159.2011.07307.x. View

19.

Wasseff S, Scherer S . Activated microglia do not form functional gap junctions in vivo. J Neuroimmunol. 2014; 269(1-2):90-3. PMC: 4048983. DOI: 10.1016/j.jneuroim.2014.02.005. View

20.

Kopkova A, Sana J, Fadrus P, Slaby O . Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors. Clin Chem Lab Med. 2018; 56(6):869-879. DOI: 10.1515/cclm-2017-0958. View